Artery Network Invites You to Join the Japan Health Industry Study Tour: Exploring New Global Opportunities for Chinese Enterprises
VCBeat
Internet Medical Health Media
Amid the current new macroeconomic landscape, it has become a market consensus that Chinese enterprises are actively expanding overseas to seek growth opportunities for their second curve.. VCBeat Goes Global, Setting Sail for the World! From August 18 to 23 this year, VCBeat led representatives from 25 healthcare companies to Indonesia, completing a six-day, five-night in-depth market exploration that received positive feedback. In December, VCBeat will set sail once again, heading toEconomic Leadership, Technological Innovation,Market ProsperityThe Hotbed of Innovation: Japan。
Japan Health and Wellness Industry Study Tour Plan
Time:December 1–5 (Five Days and Four Nights)
Location:Japan · Tokyo
Target Audience: Industry professionals, including medical entrepreneurs, corporate executives, and representatives of investment institutions in the fields of regenerative medicine, anti-aging, and traditional Chinese medicine, who are interested in learning about Japan’s cutting-edge technologies and have needs for business transformation or technical collaboration.
Why Choose Japan
▶Regulatory Leadership in Innovation: Japan’s Legal Safeguards for Regenerative Medicine
Japan asThe World’s Only Legislation on Regenerative Medicine...countries, where a robust legal and regulatory framework provides solid safeguards for technological innovation, offering Chinese enterprises a transparent and stable legal environment for entering the Japanese market.
▶ Leading R&D Technology: Leveraging Japan’s Scientific Strength in Regenerative Medicine
Japan boasts cutting-edge scientific achievements and extensive clinical application experience in the field of regenerative medicine, with remarkable outcomes in stem cell therapies for anti-aging, cardiovascular diseases, diabetes, and central nervous system disorders. Its preventive medicine and health services are at the forefront globally.Early Cancer Detection Rate Reaches 80%. and obtained in 2012Nobel Prize Awarded for Research on Induced Pluripotent Stem Cells (iPS)。
▶ Unearthing Blue Ocean Markets: The Vast Prospects of Japan’s Regenerative Medicine Market
According to Statista, the global regenerative medicine market size was approximately USD 16.9 billion in 2021 and is projected to reach USD 95.5 billion by 2030, representing a CAGR of 21.22%. Japan, as# Ranked First Among Countries with the Longest Life Expectancy, itsThe Huge Market Demand for Regenerative Medicineprovides vast development space for Chinese enterprises.
▶ Opportunities for International Cooperation: The Infinite Possibilities of China-Japan Collaboration in Regenerative Medicine
Chinese enterprises expanding into Japan is not merely a one-way process of technological learning and market expansion, but also opens the door to deep cooperation between China and Japan in the field of regenerative medicine. Both sides canScientific Research Collaboration, Technology Transfer, Talent Developmentand other areas to foster in-depth exchanges and jointly promote the development of global regenerative medicine.
▶ The Path to Brand Internationalization: Japan as a Springboard for Companies Going Global
Japan, as the world's fourth-largest economyEntering the Japanese market represents a significant step for Chinese companies to enhance their international brand awareness and influence. Successful cases and experience gained in the Japanese market will provide strong support for Chinese companies’ global market expansion and brand building.
Core Resources and Itinerary
